Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/1998
09/11/1998WO1998039443A1 Spα: A SCAVENGER RECEPTOR CYSTEINE-RICH DOMAIN-CONTAINING POLYPEPTIDE, AND MONOCLONAL ANTIBODIES THERETO
09/11/1998WO1998039441A1 Human chemokine receptor-like chemokine
09/11/1998WO1998039440A2 CALCIUM INDEPENDENT RECEPTOR OF α-LATROTOXIN, CHARACTERIZATION AND USES THEREOF
09/11/1998WO1998039437A1 Novel apoptosis-related dnas
09/11/1998WO1998039436A2 Fibroblast growth factor mutein compositions and methods of use therefor
09/11/1998WO1998039435A1 Cash (caspase homologue) with death effector domain, modulators of the function of fas receptors
09/11/1998WO1998039434A1 Methods and reagents for modulating apoptosis
09/11/1998WO1998039433A1 Complement receptor type 1 (cr1)-like sequences
09/11/1998WO1998039430A1 Methods and compositions for diagnosis and treatment of cancer
09/11/1998WO1998039426A2 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products
09/11/1998WO1998039421A2 Mammalian proteinases; oxidoreductases; gtp binding proteins; related reagents
09/11/1998WO1998039418A1 New applications of gene therapy technology
09/11/1998WO1998039415A1 Established microglia
09/11/1998WO1998039413A1 Models for haematopoiesis
09/11/1998WO1998039410A1 IλB $i(KINASES)
09/11/1998WO1998039363A2 Immunotoxins and methods of inducing immune tolerance
09/11/1998WO1998039362A1 Cytotoxic immunoglobulins from mammals
09/11/1998WO1998039361A1 A lymphocyte surface receptor that binds caml, nucleic acids encoding the same and methods of use thereof
09/11/1998WO1998039360A1 Antigenic structural peptide, antigenic and immunogenic compounds and uses for detecting, preventing and treating an hcv infection
09/11/1998WO1998039359A1 Dimeric cationic lipids on dicystine basis
09/11/1998WO1998039357A1 Method of alleviating neuropathic pain
09/11/1998WO1998039356A1 Purified and recombinant antigenic proteins associated with abdominal aortic aneurysm (aaa) disease
09/11/1998WO1998039354A1 Fas ligand compositions for treatment of proliferative disorders
09/11/1998WO1998039037A1 Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels
09/11/1998WO1998039035A1 Method and compositions for healing tissue defects and inducing hypervascularity in mammalian tissue
09/11/1998WO1998039034A2 Use of preparations containing anti-cd44 antibodies in the treatment of certain tumours and the suppression of immune reactions
09/11/1998WO1998039033A1 Costimulation of t-cell proliferation by a chimeric bispecific costimulatory protein
09/11/1998WO1998039031A1 Functional dna clone for hepatitis c virus (hcv) and uses thereof
09/11/1998WO1998039030A1 Vaccine composition for preventing or treating c hepatitis
09/11/1998WO1998039029A2 Pharmaceutical or food composition for treating pathologies related to graft versus host, allergic or autoimmune reaction
09/11/1998WO1998039026A2 Methods of therapeutic administration of anti-cd40l compounds
09/11/1998WO1998039024A1 Selective mmp inhibitors having reduced side-effects
09/11/1998WO1998039023A1 Treatment of cardiomyopathy
09/11/1998WO1998039022A1 Methods of using exendin and glp-1, and agonists and antagonists thereof, to affect the central nervous system
09/11/1998WO1998039021A1 TREATMENT AND DIAGNOSIS OF INFERTILITY USING TGFβ OR ACTIVIN
09/11/1998WO1998039020A1 Methods for treatment of scar tissue
09/11/1998WO1998039011A1 Photosensitizer conjugates for pathogen targeting
09/11/1998WO1998038990A1 Method of treating trauma associated with brain, spinal cord or peripheral nerve injury using carbobenzyloxy n-protected di- and tripeptide phenylalaninals
09/11/1998WO1998038861A1 Antisense compounds which prevent cell death and uses thereof
09/11/1998WO1998038854A1 Pharmaceutical composition and methods for using it
09/11/1998WO1998031817A3 Human lysosomal sialidase and therapeutic uses thereof
09/11/1998WO1998031795A3 Novel human metallothionein
09/11/1998WO1998031712A3 Chitosan-conjugates with acidic chelate-complex forming agents
09/11/1998WO1998031704A3 Tachykinin antagonists
09/11/1998WO1998030707A3 Eukaryotic gene expression cassette and uses thereof
09/11/1998WO1998030692A3 Human endosulfine gene
09/11/1998WO1998030687A3 Protein containing an srcr domain
09/11/1998WO1998030585A3 Use of pea3 in tumor suppression
09/11/1998WO1998030584A3 Secreted proteins and polynucleotides encoding them
09/11/1998WO1998029438A3 Cortistatin polypeptides
09/11/1998WO1998028424A3 Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily
09/11/1998WO1998027110A3 Dihydroxypropyl cysteine peptide and agent containing this peptide
09/11/1998WO1998025956A3 Human GTP-binding proteins
09/11/1998WO1998020135A3 Protease-activatable pseudomonas exotoxin a-like proproteins
09/11/1998WO1998013488A3 Process for the determination of app secretase modulators and the use thereof as agents in the treatment of alzheimer's disease
09/11/1998CA2614782A1 Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels
09/11/1998CA2284131A1 70 human secreted proteins
09/11/1998CA2284083A1 Antigenic structural peptide, antigenic and immunogenic compounds and uses for detecting, preventing and treating an hcv infection
09/11/1998CA2284078A1 A lymphocyte surface receptor that binds caml, nucleic acids encoding the same and methods of use thereof
09/11/1998CA2283474A1 Isolation of tissue specific peptide ligands and their use for targeting pharmaceuticals to organs
09/11/1998CA2283459A1 Fas ligand compositions for treatment of proliferative disorders
09/11/1998CA2283394A1 Methods and compositions for diagnosis and treatment of cancer
09/11/1998CA2283300A1 Costimulation of t-cell proliferation by a chimeric bispecific costimulatory protein
09/11/1998CA2283299A1 186 human secreted proteins
09/11/1998CA2283270A1 Treatment and diagnosis of infertility using tgf.beta. or activin
09/11/1998CA2283143A1 Pharmaceutical or food composition for treating pathologies related to graft versus host, allergic or autoimmune reaction
09/11/1998CA2283076A1 Vaccine composition for preventing or treating c hepatitis
09/11/1998CA2283068A1 Methods and compositions for the treatment of injury to the central nervous system
09/11/1998CA2282830A1 Sp.alpha.: a scavenger receptor cysteine-rich domain-containing polypeptide, and monoclonal antibodies thereto
09/11/1998CA2282827A1 Method of alleviating neuropathic pain
09/11/1998CA2282760A1 Human chemokine receptor-like chemokine
09/11/1998CA2282717A1 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products
09/11/1998CA2282709A1 Protein kinase c inhibitor-like protein (ipkc-2)
09/11/1998CA2282708A1 Adenovirus vectors specific for cells expressing carcinoembryonic antigen and methods of use thereof
09/11/1998CA2281934A1 Use of preparations containing anti-cd44 antibodies for the treatment of certain tumours and for the supression of immune reactions
09/11/1998CA2281915A1 Dimeric cationic lipids on dicystine basis
09/11/1998CA2281484A1 Cash (caspase homologue) with death effector domain, modulators of the function of fas receptors
09/11/1998CA2280134A1 Selective mmp inhibitors having reduced side-effects
09/11/1998CA2252422A1 Methods and reagents for modulating apoptosis
09/10/1998DE19711503C1 Pharmazeutische Zusammensetzung zur Aufhebung der membranvermittelten Resistenz von Zellen A pharmaceutical composition for the abolition of membrane-mediated resistance of cells
09/09/1998EP0863208A2 Histidine Kinase polypeptides, polynucleotides encluding the same and use thereof
09/09/1998EP0863207A1 RNA dependent amidotransferase A from Staphylococcus Aureus
09/09/1998EP0863157A1 Anti-metakaryocyte monoclonal antibody 97A6
09/09/1998EP0863156A1 Peptides useful as somatostatin antagonists
09/09/1998EP0863155A1 Suppression of T-cell proliferation using peptide fragments of myelin basic protein
09/09/1998EP0863154A1 Use of thiol redox proteins for reducing protein intramolecular disulfide bonds, for improving the quality of cereal products, dough and baked goods
09/09/1998EP0863152A2 Streptococcus pneumoniae Def1 protein
09/09/1998EP0863139A1 Benzoxazindione derivatives, process for their preparation and their use
09/09/1998EP0862919A1 Remedy for hepatitides
09/09/1998EP0862918A2 Therapeutic agent for canine intractable dermatitis
09/09/1998EP0862907A2 Protein extract from cereal gluten
09/09/1998EP0862642A1 Recombinant herpes virus vectors for expression in neuronal cells
09/09/1998EP0862637A1 Pseudomonas exotoxin - myelin basic protein chimeric proteins
09/09/1998EP0862634A1 Pharmaceutical composition for treating papillomavirus tumours and infection
09/09/1998EP0862633A1 Virus protein antigens of the jc virus
09/09/1998EP0862631A1 Luminal cholecystokinin-releasing factor
09/09/1998EP0862630A2 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
09/09/1998EP0862628A1 Receptor and nucleic acid molecule encoding said receptor
09/09/1998EP0862626A1 Pilosulin 2
09/09/1998EP0862625A1 Methods for modulation of cholesterol transport
1 ... 2593 2594 2595 2596 2597 2598 2599 2600 2601 2602 2603 2604 2605 2606 2607 2608 2609 2610 2611 2612 2613 ... 3163